Abeona Therapeutics (ABEO) Total Debt (2016 - 2025)
Historic Total Debt for Abeona Therapeutics (ABEO) over the last 11 years, with Q3 2025 value amounting to $19.8 million.
- Abeona Therapeutics' Total Debt rose 590.35% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year increase of 590.35%. This contributed to the annual value of $19.0 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Abeona Therapeutics' Total Debt is $19.8 million, which was up 590.35% from $19.6 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Total Debt registered a high of $34.4 million during Q2 2021, and its lowest value of $4.2 million during Q4 2022.
- In the last 4 years, Abeona Therapeutics' Total Debt had a median value of $18.6 million in 2024 and averaged $17.9 million.
- Per our database at Business Quant, Abeona Therapeutics' Total Debt soared by 2193.93% in 2021 and then plummeted by 7473.27% in 2022.
- Over the past 4 years, Abeona Therapeutics' Total Debt (Quarter) stood at $8.4 million in 2021, then plummeted by 50.6% to $4.2 million in 2022, then skyrocketed by 355.51% to $19.0 million in 2024, then grew by 4.16% to $19.8 million in 2025.
- Its Total Debt was $19.8 million in Q3 2025, compared to $19.6 million in Q2 2025 and $19.3 million in Q1 2025.